XML 54 R39.htm IDEA: XBRL DOCUMENT v3.22.2.2

EARNINGS (LOSS) PER SHARE (Tables)

9 Months Ended

Sep. 30, 2022

Earnings Per Share [Abstract]

Schedule of calculation of earnings (loss) per share

Earnings (loss) per share attributable to Bausch Health Companies Inc. were calculated as follows:

			Three Months Ended September 30,												Nine Months Ended September 30,
(in millions, except per share amounts)			2022						2021						2022						2021
Net income (loss) attributable to Bausch Health Companies Inc.			$	399					$	188					$	185					$	(1,017)
Basic weighted-average common shares outstanding			362.5						359.6						361.8						358.5
Diluted effect of stock options and RSUs			0.9						4.4						1.9						—
Diluted weighted-average common shares outstanding			$	363.4					$	364.0					$	363.7					$	358.5
Earnings (loss) per share attributable to Bausch Health Companies Inc.
Basic			$	1.10					$	0.52					$	0.51					$	(2.84)
Diluted			$	1.10					$	0.52					$	0.51					$	(2.84)

X

- References

No definition available.

+ Details

Name:	us-gaap_EarningsPerShareAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration